Hyderabad: Pharma major Dr Reddy’s Laboratories has launched over-the-counter Lansoprazole delayed-release capsules in the US market.
The Hyderabad-based company will market the product under store brand labels in the US market.
The product is the bioequivalent version of Novartis Consumer Health’s Prevacid 24 HR capsule. It had brand sales of approximately $115 million in the 12 months ending March 31, 2012, according to market estimates.
The tablets are generally indicated for treating rheumatoid arthritis and osteoarthritis.
No comments:
Post a Comment